Close
info@ihfda.org
Login

2022 Annual Conference

September 26th - 28th, 2022
Nashville, Tn

IHFDA 6th Annual Conference

We are pleased to announce details about the 2022 Annual Conference.  This years conference will be held in Nashville, Tn at the Marriot Hotel.  The upcoming agenda will address the many of emerging and ongoing issue with drug diversion in healthcare facilities.

IHFDA will be announcing the call for presentations in February.
Registration Opening Soon

Conference Agenda

Day 1
Day 2
Day 3
9/20/2021 - Monday 
10:00 A.M. - 10:15 A.M.
WELCOME AND OPENING REMARKS
10:15 A.M. – 11:15 A.M.
“OUTBREAKS OF INFECTIONS ASSOCIATED WITH DRUG DIVERSION IN HEALTHCARE”
Dr. Matthew Crist, MD, MPH, CDC
11:15 A.M. – 11:30 A.M.
BREAK WITH EXHIBITORS
11:30 A.M. – 12:30 P.M.
“CASE PRESENTATION: A REVIEW OF TWO DIVERSION CASES AT AN ACADEMIC HEALTH SYSTEM (INFUSION CENTER AND PERIOPERATIVE SETTING)”
Bailey Eason, PharmD, MS, BCPS
UVA Pharmacy Assistant Manager, Surgical Services, Neurology, and Controlled Substances
Katelyn Hipwell, PharmD, MPH
UVA Pharmacy Manager, Clinical Operations
Matthew Jenkins, PharmD, MS

12:30 P.M. – 1:00 P.M.
LUNCH / TIME WITH EXHIBITORS
1:00 P.M. – 2:00 P.M.
“PREVENTING DIVERSION AND RESPECTING THE RIGHTS OF PEOPLE IN RECOVERY: TIPS FROM TWO ATTORNEYS”
Michael Barnes, JD, Managing Principal, Sequel Health Law
Shruti Kulkarni, JD, Principal Attorney, Sequel Health Law

2:00 P.M. – 2:15 P.M.
BREAK WITH EXHIBITORS
2:15 P.M. – 3:15 P.M.
CONTROLLED SUBSTANCE DISCREPANCY MONITORING IN ANESTHESIA PRACTICE
Nicholas Jenkins, BS, CPhT
Compliance Specialist, Children’s Hospital Colorado
Heidi McNeely, MSN, RN, PCNS-BC
Drug Diversion Prevention Officer, Children’s Hospital Colorado
3:15 P.M. – 3:30 P.M.
BREAK WITH EXHIBITORS
3:30 P.M. – 4:30 P.M.
“HOW YOUR FACILITY CAN HARNESS AI TO GET AHEAD OF DRUG
DIVERSION"
Nick Culbertson, Co-Founder and CEO of Protenus
Dwight De Vera, GM Healthcare Intelligence at Inmar

4:30 P.M. – 4:45 P.M.
BREAK WITH EXHIBITORS
4:45 P.M. – 5:45 P.M.
“STANDARDIZING THE DRUG DIVERSION INVESTIGATION PROCESS” 
Teresa (Terri) Vidals,
BS Pharm, Founder Rxpert Solutions

5:45 P.M. – 6:00 P.M.
CLOSING REMARKS
9/21/2021 - Tuesday
9:00 A.M. – 9:15 A.M.
OPENING REMARKS AND HOUSEKEEPING
9:15 A.M. – 10:15 A.M.
“A CONCEPTUAL MODEL OF DRUG DIVERSION IN HEALTHCARE”
Maureen Burger MSN, RN, CPHQ, FACHE
10:15 A.M. – 11:15 A.M.
"OPIOID RELATED DEATHS IN ILLINOIS DURING THE COVID PANDEMIC"
Jenny Epstein, Assistant Deputy Director of the Office of Policy, Planning, and Statistics at the Illinois Department of Public Health
11:15 A.M. – 11:30 A.M.
BREAK WITH EXHIBITORS
11:30 A.M. – 12:30 P.M.
“NURSES, SUBSTANCE ABUSE AND BURNOUT”
Kristin ‘Kris’ Waite-Labott, RN, BSN, CARN, Nurse trainer
Dr. Michel Sucher, MD, FASM, FACEP
Steven J. Wolt, CEO, Veritus
12:30 P.M. – 1:00 P.M.
LUNCH / TIME WITH EXHIBITORS
1:00 P.M. – 2:00 P.M.
“LESSONS LEARNED ABOUT DRUG USE AND DIVERSION IN THE PANDEMIC”
Marla Weston, PhD, RN, FAAN
2:00 P.M. – 2:15 P.M.
BREAK WITH EXHIBITORS
2:15 P.M. – 3:15 P.M.
“DETECTING POTENTIAL DIVERSION THROUGH DISCREPANCY RESOLUTION”
Caroline Carter, UNC Health
3:15 P.M. – 3:30 P.M.
BREAK WITH EXHIBITORS
3:30 P.M. – 4:30 P.M.
“IMPLEMENTING RAMAN SPECTROSCOPY AT THE POINT OF CARE IN A LARGE ACADEMIC MEDICAL CENTER”
Danielle Neal, PharmD, MBA
Wake Forest Baptist Health Pharmacy Practice Leader, Drug Diversion and Compliance
Patty Penland, BSN, RN
Wake Forest Baptist Health Drug Diversion Surveillance Analyst
4:30 P.M. – 4:45 P.M.
CLOSING REMARKS/UPDATE ON THE ORGANIZATION
5:00 P.M. – 7:00 P.M.
EXHIBITOR OPPORTUNITIES
9/22/2021 - Wednesday
10:00 A.M. – 10:15 A.M.
OPENING REMARKS – HOUSEKEEPING
10:15 A.M. – 11:45 A.M.
“WHAT TO EXPECT WHEN THE DEA VISITS YOUR HOSPITAL OR HEALTHCARE FACILITY”
Dwayne A Jeffcoat, Staff Coordinator, Liaison Section, DEA
11:45 A.M. – 12:00 P.M.
BREAK / TIME WITH EXHIBITORS
12:00 P.M. – 12:45 P.M.
“REGULATORY REQUIREMENTS FROM BOTH THE DEA AND EPA RELATED TO DISPOSAL OF CONTROLLED SUBSTANCES”
Cara Simaga, Senior Director of Regulatory Affairs for Stericycle, Inc.
CHMM – Certified Hazardous Materials Manager.
12:45 P.M. – 1:00 P.M.
BREAK / TIME WITH EXHIBITORS
1:00 P.M. – 2:00 P.M.
“HOW NEW TECHNOLOGIES THAT IMPROVE PDMP EFFECTIVENESS CAN REDUCE DIVERSION OF OPIOIDS AND OTHER MEDICATIONS”
Jeffrey R. Wahl, J.D., Co-Founder and President, MIDAS Healthcare Solutions, Inc.
Neil Chatterjee, M.D., Chief Medical Officer, Scriptulate
2:00 P.M. – 2:15 P.M.
BREAK WITH EXHIBITORS
2:15 P.M. – 3:15 P.M.
“SUSPECTED DIVERSION IN YOUR ORGANIZATION?
CREATING A TECH-ENABLED BEST PRACTICE ESCALATION PLAN”
Niki Pinion, CPh.T, CCA – Controlled Substance Technician, Dayton Children’s Hospital
2:00 P.M. – 2:15 P.M.
BREAK WITH EXHIBITORS
3:30 P.M. – 4:30 P.M.
“DIVERSION CHALLENGES IN THE ANESTHESIA ENVIRONMENT”
Dr. Keith Berge, Retired anesthesiologist, Mayo Clinic, Past President, MN, Board of Medical Practice
4:30 P.M. – 4:45 P.M.
CLOSING REMARKS
5:00 P.M. – 7:00 P.M.
TIME WITH EXHIBITORS

2022 Conference Exhibitors (A-Z)

BD - IHFDA Corporate MemberBaptist Memorial Health CareMethodist Le Bonheur HealthcareProtenus
PO Box 28
Bethel, Ohio, 45106
info@ihfda.org
Quick Links
Login
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram